Management of familial melanoma

被引:42
|
作者
Bishop, Julia Newton [1 ]
Harland, Mark [1 ]
Randerson-Moor, Juliette [1 ]
Bishop, D. Timothy [1 ]
机构
[1] St James Univ Hosp, Genet Epidemiol Div, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England
来源
LANCET ONCOLOGY | 2007年 / 8卷 / 01期
关键词
D O I
10.1016/S1470-2045(06)71010-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Relatives of patients with melanoma are at increased risk of melanoma. We review the evidence that this risk may be attributed both to shared susceptibility genes (both high-penetrance and lower-penetrance genes) and shared environment. The most frequent high-penetrance susceptibility gene is CDKN2A, and environmental effects on the risk to gene carriers are evident in that CDKN2A penetrance is higher in CDKN2A-mutation-positive families living in Australia than those in Europe. We review the approaches to managing melanoma families, in which the likelihood of there being detectable CDKN2A mutations is positively correlated with the number of cases of melanoma in the family. Within families, risk that an individual carries a germline mutation can be estimated by pedigree analysis for autosomal dominant genes with incomplete penetrance. Prevention advice to families relates to moderation of sun exposure and self-examination of naevi, although there are few supportive data.
引用
收藏
页码:46 / 54
页数:9
相关论文
共 50 条
  • [31] COMPARISON OF NONFAMILIAL AND FAMILIAL MELANOMA
    BARNHILL, RL
    ROUSH, GC
    TITUSERNSTOFF, L
    ERNSTOFF, MS
    DURAY, PH
    KIRKWOOD, JM
    DERMATOLOGY, 1992, 184 (01) : 2 - 7
  • [32] Genetics of familial and sporadic melanoma
    Bataille, V
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (06) : 464 - 470
  • [33] FAMILIAL MALIGNANT-MELANOMA
    KOPF, AW
    HELLMAN, LJ
    ROGERS, GS
    GROSS, DF
    RIGEL, DS
    FRIEDMAN, RJ
    LEVENSTEIN, M
    BROWN, J
    GOLOMB, FM
    ROSES, DF
    GUMPORT, SL
    MINTZIS, MM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (14): : 1915 - 1919
  • [34] Familial Malignant Melanoma - Overview
    Tadeusz Dębniak
    Hereditary Cancer in Clinical Practice, 2 (3)
  • [35] Apparent anticipation in familial melanoma
    Goldstein, AM
    Clark, WH
    Fraser, MC
    Tucker, MA
    MELANOMA RESEARCH, 1996, 6 (06) : 441 - 446
  • [36] FAMILIAL MALIGNANT-MELANOMA
    MONK, BE
    BENNETT, JP
    BRETT, J
    DUVIVIER, A
    BRITISH JOURNAL OF PLASTIC SURGERY, 1988, 41 (03): : 316 - 318
  • [37] FAMILIAL MELANOMA AND MULTIPLE MOLES
    JOHNSON, JA
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1993, 18 (06) : 564 - 564
  • [38] Melanoma and melanoma management\
    Coates, Alan
    CANCER FORUM, 2005, 29 (02) : 62 - 62
  • [39] DYSPLASTIC NEVI AS A MELANOMA RISK FACTOR IN PATIENTS WITH FAMILIAL MELANOMA
    CAREY, WP
    THOMPSON, CJ
    SYNNESTVEDT, M
    GUERRY, D
    HALPERN, A
    SCHULTZ, D
    ELDER, DE
    CANCER, 1994, 74 (12) : 3118 - 3125
  • [40] RISK-FACTORS FOR FAMILIAL MELANOMA
    GOLDSTEIN, AM
    FRASER, MC
    TUCKER, MA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 808 - 808